Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1

Rheumatology

Volumn 43, Issue 2, 2004, Pages 181-185

  Audrain, Marie A P ^a   Colonna, Françoise ^a   Morio, Florent ^a   Hamidou, Mohamed A ^a   Muller, Jean Yves ^a  

^a HÔTEL DIEU   (France)

Author keywords

aCL; Anti 2GP1; Antiphospholipid antibodies

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; CARDIOLIPINS; EPIDEMIOLOGIC METHODS; GLYCOPROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; REAGENT KITS, DIAGNOSTIC;

EID: 1242297060     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh029     Document Type: Article

References (20)

1. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-11.
2. Matsuura E, Igasrashi Y, Fujimoto M et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992;148:3885-91.
3. Forastiero RR, Martinuzzo ME, Kordich LC, Carreras LO. Reactivity to β2-glycoprotein I clearly differentiates anticardiolipin antibodies from anti-phospholipid syndrome and syphilis. Thromb Haemost 1996;75:717-20.
4. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995;74:1120-5.
5. Arvieux J, Roussel B, Jacob MC, Colomb MG. Measurement of anti-phospholipid antibodies by ELISA using β2-glycoprotein I as an antigen. J Immunol Methods 1991;143:223-9.
6. Viard JP, Amoura Z, Bach JF. Association of anti-β2-glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992;92:181-6.
7. Harris EN, Gharavi AE, Hughes GRV. Anticardiolipin antibody testing: the need for standardization. Arthritis Rheum 1987;30:835-6.
8. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of a standardization workshop held April 4th 1986. Clin Exp Immunol 1987;68:215-22.
9. Harris EN. The second international anti-cardiolipin standardization workshop/the Kingston anti-phospholipid antibody (KAPS) study group. Am J Clin Pathol 1990;94:476-84.
10. Harris EN, Pierangeli S, Birch D. Anticardiolipin wet workshop report. Fifth International Symposium on Antiphospholipid Antibodies. Am J Clin Pathol 1994;101:616-24.
11. Abuaf N, Meyer O, Laperche S et al. Conclusions du ler atelier français de standardisation du dosage des anticorps anticardiolipine associés à la pathologie autoimmune. Ann Biol Clin (Paris) 1994;52:365-73.
12. Audrain MAP, El Kouri D, Hamidou MA et al. Value of autoantibodies to β2-glycoprotein 1 in the diagnosis of antiphospholipid syndrome. Rheumatology 2002;41:550-3.
13. Reber G, Arvieux J, Schousboe I, Boffa MC. Multicenter evaluation of the ELISA for anti-β2GP1 antibodies. J Autoimmunity 2000;15: PD21 (abstract).
14. Exner T, Triplett DA, Taberner D, Machin SJ. Guidelines for testing and revised criteria for lupus anticoagulants. SSC subcommittee for the standardization of lupus anticoagulants. Thromb Haemost 1991;65:320.
15. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
16. Loizou S. Anticardiolipin kits: techniques of antiphospholipid antibody measurements. Clin Immunol 1991;11:41-7.
17. de Moerloose P, Reber G, Vogel JJ. Anticardiolipin antibody determination: comparison of three ELISA assays. Clin Exp Rheumatol 1990;8:575-7.
18. Reber G, Arvieux J, Comby E et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. Thromb Haemost 1995;75:444-52.
19. Favoloro EJ, Sivestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology 1999;31:142-7.
20. Reber G, Schousboe I, Tincani A et al. Inter-laboratory variability of anti-β2-glycoprotein 1 measurement. A collaborative study in the frame of the European Forum on Antiphospholipid Antibodies Standardization Group. Thromb Haemost 2002;88:66-73.